iCarbonX
$1Bpaper valuation
// OVERVIEW
iCarbonX spent eight years convincing Chinese venture capital that personalized genomics could predict health outcomes better than doctors — then disappeared so completely from public view that its current operational status is a legitimate research question. The company raised over $600 million to build an AI-powered digital health ecosystem and has produced almost no publicly verifiable evidence that the ecosystem exists at commercial scale.
// HQ
Shenzhen, China
// STATUS
PRIVATE
// FOUNDED
2015
// TIER
The Unicorn Herd · $1B – $9.9B
// PRIMARY SECTOR
ai
// FOUNDERS
// FUNDING ROUNDS
// SECTORS SERVED
// TECHNOLOGY
iCarbonX claims to integrate genomic sequencing, microbiome analysis, metabolic profiling, and behavioral data into a unified AI platform that generates personalized health recommendations. The technical architecture is proprietary and the validation methodology is unpublished. What is documented: partnerships with BGI Genomics for sequencing infrastructure and a mobile app called Meum that appears to have limited active users outside China.
// WOWLS ASSESSMENT
The company has not disclosed revenue, customer metrics, clinical validation studies, or product traction since 2018. Founder Jun Wang — formerly of BGI Genomics — raised $600 million by 2017 and then went strategically silent as Western genomics competitors like 23andMe, Helix, and Color Genomics struggled to build sustainable consumer businesses around genetic data. iCarbonX's Chinese market insulation bought time that its Western competitors did not have, but eight years without disclosed traction suggests the fundamental problem — consumers do not pay recurring subscriptions for genetic insights they cannot act on — applied in Shenzhen exactly as it did in San Francisco. The valuation exists in a regulatory and disclosure vacuum where no external price discovery has occurred since the Series A.
// WHY WOWLS HUNTS THIS
Because a unicorn valuation maintained through eight years of radio silence is either the most successful stealth health tech deployment in history or evidence that private market valuations can persist indefinitely without any connection to commercial reality. The company collected enough genetic and health data from early Chinese users to be strategically valuable even if the consumer business failed — which makes iCarbonX either a genomic data broker that never needed to disclose its pivot or a cautionary tale about the distance between precision medicine promises and sustainable unit economics.
// VALUATION NOTE
Last documented valuation from 2017 Series A. No subsequent rounds disclosed. Operational status unconfirmed.
VERDICT: VAPORWARE ASCENDANT — iCarbonX raised $600 million to build personalized genomics AI and then vanished so thoroughly that confirming whether the company still operates requires Mandarin-language SEC equivalent filings that may not exist
// PACK DEBATE
// PACK DEBATE — be the first to weigh in
Google account required — no spam, no nonsense
// LOADING INTEL…
// BROADCAST INTEL
// SIMILAR TARGETS
// INTEL UPDATED: MAY 2026
// INTELLIGENCE DISCLAIMER: Assessments represent editorial opinion based on publicly available data including filings, press reports, and market data as of the date shown. Valuations are approximate. Not financial or investment advice.
// FULL NETWORK ACCESS
🚀 Founder Briefing: Instantly sort investors by Sector, Stage, & Round — direct links to websites for all 1,030 unicorns & backing VCs included.
Don't just track iCarbonX.
Master the entire 1,030 unicorn company intelligence network.
Stop analyzing tech monopolies one page at a time. Instantly filter, sort, and isolate the exact venture capital firms, angel investors, and corporate funds backing your specific market vertical. Find investors that fit your sector and deploy your pitch with direct outbound links to every target asset in the database — 1,030 targets total.
Acquire Intel →// 5 TIERS · PAYPAL SECURED
// ENGAGE THE FULL ARSENAL
Done reading on iCarbonX?
Unlock the entire 1,030-company hitlist and 1,030 investor contacts.
Full structural breakdowns. Founder dossiers. VC outreach data. Threat-level intel updated continuously.
→ Deploy 5-Tier Order Form// ARBAN · ZUUN · MINGHAN · TUMEN · KHAN